Stay updated on Sorafenib Nivolumab in Liver Cancer Clinical Trial
Sign up to get notified when there's something new on the Sorafenib Nivolumab in Liver Cancer Clinical Trial page.

Latest updates to the Sorafenib Nivolumab in Liver Cancer Clinical Trial page
- Check6 days agoChange DetectedA new citation for a 2026 JHEP Reports article is added to Publications, listing the authors and providing full bibliographic details including the DOI and online-ahead-of-print status.SummaryDifference0.0%

- Check13 days agoChange DetectedThe page's revision metadata was updated to v3.5.3, replacing the previous v3.5.2 to reflect the latest documentation state.SummaryDifference0.0%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedSite revision updated from v3.5.0 to v3.5.2, indicating an updated build of the page.SummaryDifference0.0%

- Check56 days agoChange Detected- Publications section was added, including a new PubMed reference: Phase II trial with nivolumab and sorafenib in HCC identified enrichment of immunosuppressive monocytes in patients with Child-Pugh B liver dysfunction. These publications are automatically filled from PubMed.SummaryDifference0.4%

- Check63 days agoChange DetectedPage revision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check91 days agoChange DetectedRevision: v3.4.2 was added. The funding-status notice about a lapse in government funding and the Revision: v3.4.1 notice were removed.SummaryDifference0.4%

Stay in the know with updates to Sorafenib Nivolumab in Liver Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sorafenib Nivolumab in Liver Cancer Clinical Trial page.